Walleye Trading LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 388 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$752,976
-44.6%
16,600
-49.8%
0.00%
-50.0%
Q2 2023$1,358,093
+1.9%
33,100
-11.3%
0.00%
+33.3%
Q1 2023$1,333,102
+59.6%
37,300
+68.7%
0.00%0.0%
Q4 2022$835,321
+7.4%
22,116
+25.7%
0.00%
+50.0%
Q3 2022$778,000
-18.8%
17,600
-32.0%
0.00%
-33.3%
Q2 2022$958,000
+2.0%
25,900
-16.2%
0.00%0.0%
Q4 2021$939,000
-54.0%
30,895
-49.3%
0.00%
-62.5%
Q3 2021$2,043,000
+206.8%
60,919
+264.8%
0.01%
+300.0%
Q2 2021$666,000
-48.6%
16,700
-42.0%
0.00%
-66.7%
Q1 2021$1,295,000
-29.8%
28,800
-11.7%
0.01%
-14.3%
Q4 2020$1,844,000
-43.6%
32,612
-52.7%
0.01%
-61.1%
Q3 2020$3,271,000
-18.0%
68,935
+1.9%
0.02%
-30.8%
Q2 2020$3,988,000
-26.7%
67,647
-41.2%
0.03%
-38.1%
Q1 2020$5,442,000
-0.1%
115,110
+27.7%
0.04%
+13.5%
Q4 2019$5,446,000
+1364.0%
90,145
+1354.0%
0.04%
+1133.3%
Q3 2019$372,000
-93.3%
6,200
-92.9%
0.00%
-93.8%
Q2 2019$5,579,000
+3.7%
86,799
+31.0%
0.05%
+14.3%
Q1 2019$5,378,000
-7.2%
66,249
-38.2%
0.04%
-2.3%
Q4 2018$5,795,000
+29.0%
107,185
+23.1%
0.04%
+79.2%
Q3 2018$4,492,000
+108.5%
87,100
+68.5%
0.02%
+100.0%
Q2 2018$2,154,000
+772.1%
51,679
+740.3%
0.01%
+500.0%
Q1 2017$247,000
+12250.0%
6,150
+12200.0%
0.00%
Q1 2016$2,000
-95.7%
50
-93.3%
0.00%
Q4 2015$46,0007500.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
BB BIOTECH AG 6,529,838$404,393,00011.39%
DOWLING & YAHNKE LLC 676,379$41,888,0005.27%
Opus Point Partners Management, LLC 102,459$6,345,0004.19%
WILLIAM HARRIS INVESTORS INC 230,443$14,271,0003.43%
PINNACLE ASSOCIATES LTD 1,690,263$104,678,0002.20%
MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ 21,298$1,319,0002.11%
Sonora Investment Management, LLC 126,763$7,850,0002.04%
Virtus ETF Advisers LLC 10,447$647,0001.78%
Apex Capital Management 1,020,096$63,175,0001.41%
PERKINS CAPITAL MANAGEMENT INC 19,900$1,232,0001.32%
View complete list of IONIS PHARMACEUTICALS INC shareholders